Industry landscapes
The companies, capital and talent shaping healthtech in Denmark. Find the leaders. Understand the segments. See where the activity is.
An industry ecosystem,
measured in context.
24 featured companies from the funding, hiring, revenue and team-size leaderboards.
Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗
No company example met every recorded classification, independence and public-profile gate in this snapshot. The live directory may have newer qualifying companies.
Explore classified startups in Radar ↗A few useful ratios bring the size of this ecosystem into perspective.
37 of 508 tracked companies have open roles.
115 of 508 tracked companies have a recorded round.
Share of disclosed capital received by the three largest recorded recipients.
Midpoint of 283 rounds with a disclosed amount.
Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 28.4% of disclosed capital, while 77.4% of tracked companies have no recorded funding round.
Explore the segments →Recorded company formation and disclosed funding across the complete annual series shown.
Sum of recorded funding rounds · USD
| Year | Funding (USD) | Founded | Raising |
|---|---|---|---|
| 2016 | $38.02M | 26 | 29 |
| 2017 | $49.26M | 27 | 26 |
| 2018 | $103.41M | 39 | 34 |
| 2019 | $106.44M | 28 | 41 |
| 2020 | $114.69M | 28 | 36 |
| 2021 | $125.37M | 20 | 26 |
| 2022 | $103.67M | 18 | 17 |
| 2023 | $82.93M | 10 | 11 |
| 2024 | $69.9M | 8 | 7 |
| 2025 | $145.03M | 0 | 7 |
Share of all disclosed company funding.
316 recorded rounds since 2016
Recorded participation in healthtech company rounds since 2016.
Backed by New Enterprise Associates and Lilly and others.
Backed by Prosus and Atomico and others.
Backed by A P Moller Holding.
Backed by Novo Holdings and Forbion.
Backed by Vaekstfonden and Chr. Augustinus Factories and others.
Backed by Cipio Partners and Chr. Augustinus Factories and others.
Backed by Chr. Augustinus Factories and Vaekstfonden and others.
Backed by North-East and Lauxera Capital Partners and others.
Backed by Plural and Antler and others.
Backed by North Ventures and Danmarks Eksport og Investeringsfond and others.
Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.
Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.
FY2017 · annual statements grouped by reported fiscal year; exact entity periods remain on preview rows · 16 reporting entities from 177 eligible matches.
Sum of reporting-entity revenue; not Denmark market sales.
Combined result for the same cohort.
Combined net income ÷ combined revenue.
The middle covered reporting entity.
7 of 16 covered entities.
Share of covered revenue from the five largest entities.
Reported cohort totals by year; coverage is stated for every period.
Bar height shows revenue. Changes in coverage can affect totals.
FY2017 · 16 reporting entities
Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.
| Company / reporting entity | Revenue | Net profit / loss | Net margin | Revenue growth | Total assets |
|---|---|---|---|---|---|
| Widex ↗15771100 | DKK 1,689.2m | DKK 357.4m | +21.2% | — | — |
| Stella Care ↗34472416 | DKK 6.0m | DKK 0.6m | +10.5% | — | — |
| byACRE ↗30606280 | DKK 1.0m | DKK -0.3m | -26.5% | — | — |
| PicoTeam ↗33246153 | DKK 0.3m | DKK -0.0m | -7.6% | — | — |
| SENS Motion ↗36024860 | DKK 0.3m | DKK -0.7m | -276.9% | — | — |
| Reapplix ↗31261570 | DKK 0.1m | DKK -17.2m | -24240.0% | — | — |
| 3Shape ↗31473233 | DKK 0.0m | DKK 458.0m | — | — | — |
| Guldmann ↗27706746 | Financial figure available in Radar | Financial figure available in Radar | Financial figure available in Radar | Financial figure available in Radar | Financial figure available in Radar |
Explore full company accounts and filings.
Choose “View accounts” to inspect an available company preview.
Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.
| Industry | Covered / eligible | Revenue total | Median revenue | Net profit / loss | Aggregate margin | Profitable share | Overlap |
|---|
Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.
Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.
The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.
Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.
How the Denmark companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.
8 of the 508 companies on this page carry a measured traffic record (1.6%); these are the largest of those, by monthly visits. The median among them is 167,063 visits.
| Company | Monthly visits | Authority | Mobile |
|---|---|---|---|
| Apoproapopro.dk | 414,917 | 47 | 76.7% |
| SYNLAB Medical Digital Servicessmds.dk | 286,944 | 28 | 83.2% |
| Novo Medlinknovomedlink.com | 261,530 | 48 | 77.2% |
| ReSoundresound.com | 200,266 | 50 | 60.9% |
| Miiskinmiiskin.com | 133,861 | 48 | 48.6% |
| EasyPracticeeasypractice.net | 119,473 | 33 | 22.9% |
| Coloplastcoloplast.com | 93,406 | 38 | 49.8% |
| Widexwidex.com | 79,418 | 46 | 46.5% |
Visits and authority are third-party web estimates, not company-reported figures.
78 of these companies (15.4%) publish at least one Android app — 134 apps in all, carrying 16.4M installs between them.
| App | Installs | Rating | Store category |
|---|---|---|---|
| Signia AppWS Audiology | 3M | 2.7 | Medical |
| Oticon CompanionOticon | 1.9M | 4.2 | Medical |
| MinSundhedsundhed.dk | 1.8M | 3.2 | Medical |
| ReSound Smart 3DReSound | 1.7M | 4.4 | Medical |
| ReSound Tinnitus ReliefReSound | 895.8K | 4.5 | Health & Fitness |
| klarify: Pollen & Allergy Appklarify | 812.1K | 3.8 | Health & Fitness |
| Way of Life: habit trackerWay of Life | 734.7K | 3.6 | Productivity |
| WIDEX MOMENTWS Audiology | 543.3K | 2.2 | Medical |
| Rexton AppWS Audiology | 541.4K | 2.6 | Medical |
| Miiskin Skin & DermatologyMiiskin | 481.3K | 3.8 | Health & Fitness |
Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.
The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q3–2026Q2).
| Segment | Apps | Installs | Leading app | Release trend |
|---|---|---|---|---|
| Assistive Tech | 28 | 11M | Signia App 3M | |
| Ent Disorders | 27 | 11M | Oticon Companion 1.9M | |
| Disease Self Management | 49 | 6.6M | MinSundhed 1.8M | |
| Wearable Technology | 24 | 1.1M | WIDEX TONELINK 351.6K | |
| Healthcare Booking Platforms | 8 | 949.6K | klarify: Pollen & Allergy App 812.1K | |
| Healthcare It | 55 | 687.9K | Medical Lab Tests 235.6K | |
| Fitness & Wellness Tech | 19 | 440.1K | Liva 65K | |
| Saas | 2 | 154.4K | Lenus eHealth 150.6K |
A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.
New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.
Darker bars are new releases, lighter bars apps updated. 97 of 134 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.
Explore the segments behind the headline numbers.
Rank segments by scale, hiring or disclosed funding.
Companies can sit in several segments. Counts and funding overlap.
The largest measured segment in this report snapshot.
22 companies hiring · $995.68M disclosed funding
Explore in RadarCommon revenue models; a company can use more than one.
Recorded corporate activity linked to companies in this landscape.
Dawn Health has raised €21.5 million in a growth investment round to address that gap and expand its AI-enabled patient companion platform.
The private placement provides the financial flexibility to advance our strategic priorities, including completing data collection, submitting a pre-submission to the FDA, and initiating the Validation Study in BioPorto’s U.S. clinical trial, while strengthening our commercial platform.
Cerebriu (€15M series A, automating MRI workflows).
Kreston Reeves has advised the shareholders of The Koppa Company Limited, trading as Rapidcare, on its sale to the Danish medical technology group Qufora.
Teton.ai ... secured a $20 million Series A round to expand its AI‑powered predictive care platform for nursing and senior living facilities.
Copenhagen-based Ventriject, a MedTech startup behind technology that accurately measures cardiorespiratory fitness (CRF), has just closed a €1.7 million funding round following expansion into several European markets.
Droplet IV today announced the successful completion of a $2 million funding round to enable launch of its first automatic IV-line flushing device in the EU and US markets.
Danish medtech company Brainreader has raised €6.6 million to accelerate the global rollout of its AI-driven diagnostic platform Neuroreader.
Danish incontinence device company Magcath secures €535 in new funding for the company’s European launch.
Medtrace Pharma A/S raised $30 million in a series B round to ramp its platform for production, infusion and analysis of 15O-water in medical imaging.
Top 10 categories among 75 recorded events in the 24-month window.
11 tracked people moves
Appointment president, US Wholesale
Appointment Executive Vice President and Chief Financial Officer
Appointment Senior Vice President, Portfolio & Product Strategy
Resignation Previously "Chief Financial Officer"
Appointment Chief Executive Officer
Resignation Previously Chief Executive Officer
Appointment Creative Director
Appointment Director of Marketing
1 recorded customer wins
Customer: Sunay Healthcare SupplyHealthcare
1 companies with reported reductions
200 rolescost reduction
Company-linked deal reports; status is preserved as recorded.
| Acquirer → target | Status | Date | Value / context |
|---|---|---|---|
| origio a/s→Trivector Scientific | Announced | 2026-01-09 | Not stated in snapshot |
| Qufora→rapidcare | 2025-10-27 | Not stated in snapshot | |
| Liva Healthcare→Discover Momenta | Announced | 2025-05-02 | Not stated in snapshot |
| William Demant→OHRWERK Group | Announced | 2025-02-04 | Not stated in snapshot |
| William Demant→OHRWERK Gruppe | Pending | 2025-01-24 | Not stated in snapshot |
| principal technologies→Vivostat ↗ | Pending | 2024-12-11 | Not stated in snapshot |
A discussion or rumour is not a completed transaction. An unstated value is not zero.
Recorded hiring and workforce signals from the available source snapshot.
No repeated job title is supported by this snapshot.
0 tracked postings mention remote work.
| Company | Employees |
|---|---|
| demant a/s ↗ | 20,922 |
| Ambu ↗ | 4,917 |
| 3Shape ↗ | 2,431 |
| Health Data Authority ↗ | 316 |
| Apoteka ↗ | 143 |
| Auditdata ↗ | 106 |
| dantec dynamics ↗ | 79 |
| Dawn Health ↗ | 76 |
355 founders and chief executives across 227 companies.
Novo Holdings, ex-Lundbeck, Technology Transfer Unit, Tech Transfer Office. University of Copenhagen MS 2005
Ex- Co-Founder - Hivy.co, substans softwareudvikling. DTU - Technical University of Denmark BS, MS & PhD
Blue Ocean Robotics, Wallmo A/S, ex-Fionia Lighting A/S, University of Southern Denmark, Triax A/S. Technical University of Denmark eMBA 2003
Founder Jazzhus Montmartre, ex- Co-founder SundhedsDoktor, Saxo Bank, Kulturministeriet. Danish School of Journalism 1989.
Ex-Urgo Medical North America. Brown University BA 1997, Harvard Business School MBA 2003
Ex-Labster, Mailbird, Livit Ecosystem, PANDORA, KPMG. AU-HIH BS 2006, Aarhus School of Business MSc 2011
University of Southern Denmark 2005
Co-Founder Norlase, ex- CEO RSP Systems & Flux, Sonion, NKT Integration, CEO Cisilias, Teem Photonics. Technical University of Denmark PhD 1999
Cerebriu, ex-University Of Copenhagen, ex-Biomediq, University of Copenhagen, 2014
Aarhus university 2013, Aalborg University 2017, Seoul National University of Science and Technology 2017, DTU - Technical University of Denmark 2019
University College Lillebaelt BS 2012, Faculty of Engineering, University of Southern Denmark BEng 2015 & MEng 2017.
Ex- Founder Corporate BarEvent & EtOH, Co-Founder Boligmaerket & Flooid, GroupM, Inchcph, Clausen, Nexus, Militaeet. HRS 2009, cph business 2014
18 profiles with education records.
0 profiles with prior-work records.
Profiles cover recorded founders and leaders; contact details remain in Radar.
174,756 articles in the measured 12-month window.
Healthtech coverage across Denmark · articles per complete quarter
| Quarter | Articles |
|---|---|
| 2021Q2 | 21,893 |
| 2021Q3 | 22,111 |
| 2021Q4 | 21,102 |
| 2022Q1 | 23,809 |
| 2022Q2 | 23,096 |
| 2022Q3 | 23,745 |
| 2022Q4 | 31,092 |
| 2023Q1 | 29,582 |
| 2023Q2 | 26,843 |
| 2023Q3 | 28,474 |
| 2023Q4 | 25,400 |
| 2024Q1 | 32,871 |
| 2024Q2 | 41,664 |
| 2024Q3 | 38,237 |
| 2024Q4 | 39,568 |
| 2025Q1 | 61,164 |
| 2025Q2 | 32,750 |
| 2025Q3 | 106,457 |
| 2025Q4 | 16,127 |
| 2026Q1 | 27,742 |
Article volume measures coverage, not market sales.
139 recorded company events across 22 companies; percentages use that event total.
Healthtech coverage across Denmark · ranked by full-period article count.
Recent and prior counts use the source comparison windows.
Healthtech coverage across Denmark
| Keyword | Recent | Prior | Change |
|---|---|---|---|
| countries | 4,189 | 1,858 | 125% |
| geopolitical alliances | 792 | 484 | 64% |
| diplomatic strategies | 593 | 371 | 60% |
| tariff negotiations | 586 | 247 | 137% |
| multilateral diplomacy | 560 | 178 | 215% |
| foreign policy analysis | 409 | 203 | 101% |
| drone warfare | 310 | 13 | 2285% |
| diplomatic engagements | 281 | 196 | 43% |
| study overseas | 278 | 96 | 190% |
| national security strategy | 276 | 105 | 163% |
| europa league | 118 | 715 | -83% |
| quarterfinals | 154 | 436 | -65% |
| final match | 80 | 415 | -81% |
| olympic trials | 80 | 232 | -66% |
| summer olympics athletics | 9 | 139 | -94% |
Healthtech coverage across Denmark
territories, disputed islands, countries
6.6% critical · 5.1% positivequarterfinals, world cup, europa league
39.8% critical · 44.0% positiveoffshore wind farms, league expansion news, gdp growth rate
32.3% critical · 47.7% positiveHealthtech coverage across Denmark. Topic labels describe recorded classifications and can include broad context.
53,214 papers in the recorded worldwide scope.
Tone counts: 46,301 positive · 2,052 neutral · 4,861 negative.
Landmark: Implementation strategies: recommendations for specifying and reporting
Landmark: Deep Learning for Health Informatics
Landmark: Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science
Common problems researchers identify · 0119.0% of this theme group
Researchers examine obstacles to building resilient health care systems and the factors that undermine system stability.
Health informatics (400) · Health administration (281) · Nursing research (250) · Public health (273)
Resilient Health Care: a systematic review of conceptualisations, study methods and factors that develop resilience
Health systems resilience in practice: a scoping review to identify strategies for building resilience
| Year | Share index |
|---|---|
| 2022 | 23.2 |
| 2023 | 21.1 |
| 2024 | 27.6 |
| 2025 | 44.8 |
Common problems researchers identify · 0218.9% of this theme group
Papers highlight difficulties in discovering and repurposing drugs for multifactorial diseases and the regulatory hurdles involved.
Drug discovery (321) · Drug (197) · Drug development (103) · Disease (155)
A perspective on multi‐target drug discovery and design for complex diseases
Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
| Year | Share index |
|---|---|
| 2022 | 157.3 |
| 2023 | 161.8 |
| 2024 | 169.7 |
| 2025 | 211.5 |
Common problems researchers identify · 0315.9% of this theme group
Studies identify practical, equity, and acceptance issues that limit the impact of digital health tools on universal coverage.
Digital health (627) · Health care (357) · Digital transformation (69) · eHealth (97)
Technology and Universal Health Coverage: Examining the role of digital health
Engagement With and Acceptability of Digital Media Platforms for Use in Improving Health Behaviors Among Vulnerable Families: Systematic Rev
| Year | Share index |
|---|---|
| 2022 | 538.7 |
| 2023 | 553.0 |
| 2024 | 540.4 |
| 2025 | 843.9 |
Common problems researchers identify · 0414.7% of this theme group
Research points to logistical, quality, and sustainability problems affecting telemedicine and telerehabilitation services.
Telemedicine (604) · Telehealth (394) · Health care (334) · Telerehabilitation (53)
Opportunities and challenges for telehealth within, and beyond, a pandemic
Strategies for Evaluating Telehealth
| Year | Share index |
|---|---|
| 2022 | 542.2 |
| 2023 | 554.7 |
| 2024 | 541.1 |
| 2025 | 844.0 |
Common problems researchers identify · 0511.7% of this theme group
Works discuss diagnostic, biomarker, and resistance challenges that impede personalized cancer treatment strategies.
Precision medicine (480) · Personalized medicine (238) · Disease (116) · Precision oncology (28)
Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance
Personalizing Oncology: Perspectives and Prospects
| Year | Share index |
|---|---|
| 2022 | 1255.2 |
| 2023 | 1115.6 |
| 2024 | 1012.0 |
| 2025 | 1296.9 |
Common problems researchers identify · 0610.9% of this theme group
Authors address safety concerns, risk analysis, and the need for updated regulatory frameworks for emerging devices.
Medical device (221) · Wearable computer (50) · Medical equipment (27) · Risk analysis (34)
Energy sources and their development for application in medical devices
Medical Devices and Health — Creating a New Regulatory Framework for Moderate-Risk Devices
| Year | Share index |
|---|---|
| 2022 | 40.4 |
| 2023 | 42.2 |
| 2024 | 43.7 |
| 2025 | 72.1 |
Common problems researchers identify · 078.8% of this theme group
Analyses explore how COVID‑19 amplified usage pressures and highlighted gaps in remote clinical care delivery.
Pandemic (394) · Coronavirus disease 2019 (274) · 2019-20 coronavirus outbreak (69) · Telemedicine (258)
Quantifying the Impact of COVID-19 on Telemedicine Utilization: Retrospective Observational Study
Telemedicine Evaluations in Neuro-Ophthalmology During the COVID-19 Pandemic: Patient and Physician Surveys
| Year | Share index |
|---|---|
| 2022 | 655.3 |
| 2023 | 440.6 |
| 2024 | 327.7 |
| 2025 | 212.1 |
Cautions · 0119.8% of this theme group
Cautionary studies assess outcome improvements, patient satisfaction, and efficiency of telehealth across chronic conditions.
Telemedicine (762) · Telehealth (476) · Telerehabilitation (118) · Health care (319)
The Role of Telemedicine in Improving Healthcare Outcome: A Review
Assessing the Efficiency and Patient Satisfaction of Telemedicine in Managing Chronic Health Conditions
| Year | Share index |
|---|---|
| 2022 | 51.7 |
| 2023 | 48.4 |
| 2024 | 44.2 |
| 2025 | 63.5 |
Cautions · 0219.8% of this theme group
Research warns of technical, infrastructural, and quality‑assessment challenges when deploying e‑health solutions.
Health informatics (239) · Health administration (157) · Nursing research (113) · Medical device (92)
Challenges of using e-health technologies to support clinical care in rural Africa: a longitudinal mixed methods study exploring primary hea
Development and analysis of quality assessment tools for different types of patient information – websites, decision aids, question prompt l
| Year | Share index |
|---|---|
| 2022 | 23.2 |
| 2023 | 21.1 |
| 2024 | 27.6 |
| 2025 | 44.8 |
Cautions · 0315.3% of this theme group
Papers discuss uncertainties in biomarker validation, predictive modeling, and regulatory acceptance for personalized therapies.
Drug discovery (202) · Drug (160) · Pharmacogenomics (109) · Pharmacogenetics (64)
Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape
Can We Predict Clinical Pharmacokinetics of Highly Lipophilic Compounds by Integration of Machine Learning or In Vitro Data into Physiologic
| Year | Share index |
|---|---|
| 2022 | 154.6 |
| 2023 | 158.9 |
| 2024 | 165.9 |
| 2025 | 206.7 |
Cautions · 0414.7% of this theme group
Studies highlight usability, efficacy, and ethical issues surrounding digital tools for psychological and aging‑related health.
Digital health (480) · Psychological intervention (265) · Mental health (159) · Health care (262)
Digital Health Interventions to Enhance Prevention in Primary Care: Scoping Review
Digital Health Interventions for Promoting Healthy Aging: A Systematic Review of Adoption Patterns, Efficacy, and User Experience
| Year | Share index |
|---|---|
| 2022 | 790.2 |
| 2023 | 807.5 |
| 2024 | 810.9 |
| 2025 | 1159.7 |
Cautions · 0511.2% of this theme group
Analyses reveal clinician resistance, workflow integration, and equity problems that emerged during pandemic telemedicine expansion.
Pandemic (431) · Coronavirus disease 2019 (360) · Telemedicine (348) · 2019-20 coronavirus outbreak (77)
Community Mental Health Clinicians’ Perspectives on Telehealth During the COVID-19 Pandemic: Mixed Methods Study
Exploring Ophthalmologists’ Adoption of Telemedicine during the COVID-19 Pandemic: A Mixed Methods Study
| Year | Share index |
|---|---|
| 2022 | 544.1 |
| 2023 | 376.7 |
| 2024 | 243.3 |
| 2025 | 191.2 |
Cautions · 0610.3% of this theme group
Research cautions about limited awareness, adoption barriers, and evidence gaps in applying personalized oncology approaches.
Precision medicine (249) · Personalized medicine (164) · Cancer (103) · Oncology (57)
Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Sur
Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy—A Narrative Review
| Year | Share index |
|---|---|
| 2022 | 767.8 |
| 2023 | 1043.6 |
| 2024 | 798.0 |
| 2025 | 771.4 |
Cautions · 078.8% of this theme group
Papers examine transparency, bias, and reliability concerns when deploying artificial intelligence for precision diagnostics.
Applications of artificial intelligence (102) · Transformative learning (77) · Health care (188) · Precision medicine (102)
Artificial intelligence in healthcare: revolutionizing precision medicine, predictive analytics, and ethical considerations in autonomous di
Artificial Intelligence in Medicine: Transforming Diagnosis, Treatment, and Healthcare Delivery
| Year | Share index |
|---|---|
| 2022 | 534.7 |
| 2023 | 549.6 |
| 2024 | 538.1 |
| 2025 | 839.2 |
Opportunities · 0118.0% of this theme group
Opportunities focus on improving usability, integration, and evidence‑based models for health informatics and digital interventions.
Digital health (282) · Health care (348) · Health informatics (142) · Psychological intervention (156)
Development of an Evidence-Based Conceptual Model of the Health Care Sector Under Digital Transformation: Integrative Review
HCI-modelling for improving the clinical usability of digital health technologies
| Year | Share index |
|---|---|
| 2022 | 541.3 |
| 2023 | 554.6 |
| 2024 | 543.2 |
| 2025 | 853.3 |
Opportunities · 0216.6% of this theme group
Research highlights novel computational screening and docking methods that accelerate discovery of therapeutic candidates.
Drug discovery (282) · In silico (99) · Drug (156) · Docking (85)
Exploring Cimetidine\nas a Potential Therapeutic Attenuator\nagainst Amyloid Formation in Parkinson’s Disease: Spectroscopic\nand Microscopi
Design, Synthesis,\nand Biological Evaluation of 5‑Formyl-pyrrolo[3,2‑<i>b</i>]pyridine-3-carboxamides as New Selective, Potent,
| Year | Share index |
|---|---|
| 2022 | 167.5 |
| 2023 | 172.4 |
| 2024 | 180.4 |
| 2025 | 218.9 |
Opportunities · 0313.8% of this theme group
Studies showcase how molecular docking and chemical space exploration enable targeted therapeutic development.
Drug discovery (535) · Computational biology (222) · Drug (223) · Chemical space (66)
Assessing molecular docking tools: understanding drug discovery and design
Molecular Docking in Computer-Aided Drug Discovery: A Powerful Tool for Targeted Therapeutics
| Year | Share index |
|---|---|
| 2022 | 281.3 |
| 2023 | 298.1 |
| 2024 | 330.7 |
| 2025 | 367.6 |
Opportunities · 0413.7% of this theme group
Works explore new telemedicine models for physical therapy, palliative care, and senior health services.
Telemedicine (475) · Telehealth (353) · Telerehabilitation (87) · Physical therapy (75)
Urgent and non-emergent telehealth care for seniors: Findings from a multi-site impact study
Telehealth for the study of palliative care communication: opportunities, methodological challenges, and recommendations
| Year | Share index |
|---|---|
| 2022 | 51.7 |
| 2023 | 48.4 |
| 2024 | 44.2 |
| 2025 | 63.5 |
Opportunities · 0512.7% of this theme group
Papers present strategies leveraging pharmacogenomics and deep learning to tailor treatments for complex diseases.
Precision medicine (283) · Personalized medicine (216) · Disease (142) · Pharmacogenomics (61)
Pathways to personalized medicine—Embracing heterogeneity for progress in clinical therapeutics research in Alzheimer's disease
Deep Learning for Precision Medicine: Advancing Personalized Treatment Plans in Oncology
| Year | Share index |
|---|---|
| 2022 | 1255.2 |
| 2023 | 1115.6 |
| 2024 | 1012.0 |
| 2025 | 1296.9 |
Opportunities · 0612.7% of this theme group
Research emphasizes remote patient monitoring innovations using wearables and Internet‑of‑Things platforms.
Wearable computer (117) · Medical device (84) · Remote patient monitoring (76) · Internet of Things (49)
Wearable technology. Health-care solutions for a growing global population.
IoT Based Effective Wearable Healthcare Monitoring System For Remote Areas
| Year | Share index |
|---|---|
| 2022 | 40.5 |
| 2023 | 42.2 |
| 2024 | 44.3 |
| 2025 | 74.3 |
Opportunities · 0712.5% of this theme group
Studies focus on bioinformatics and circulating tumor cell analysis to refine personalized cancer therapies.
Cancer (241) · Precision medicine (207) · Breast cancer (90) · Lung cancer (44)
Bioinformatics-Based Analysis of Circulating Tumor Cells: A Methodological Overview of Personalized Cancer Treatment
[Molecular biomarkers in breast cancer : advances in precision medicine].
| Year | Share index |
|---|---|
| 2022 | 776.6 |
| 2023 | 1055.1 |
| 2024 | 810.2 |
| 2025 | 787.3 |
Orientation shares compared with 25,000 papers in the reference sample.
| Research orientation | This field | Reference sample |
|---|---|---|
| Promising | 29.7% | 37.3% |
| Problem-identifying | 29.0% | 9.7% |
| Descriptive | 18.8% | 17.3% |
| Breakthrough | 12.7% | 26.5% |
| Cautionary | 6.4% | 4.5% |
| Comparative | 2.5% | 3.9% |
| Critical | 0.9% | 0.9% |
Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.
| Concern / example paper | Papers | Share | Raised as a problem | Worldwide share |
|---|---|---|---|---|
| Privacy & surveillanceThe future of digital health with federated learning | 4,573 | 2.66% | 2,251 (49.2%) | 2.66% |
| Safety & misuseImpact of Rumors and Misinformation on COVID-19 in Social Media | 292 | 0.17% | 167 (57.2%) | 0.17% |
| Bias & fairnessChallenges and recommendations for wearable devices in digital health: Data quality, interoperability, health equity, fa | 99 | 0.06% | 45 (45.5%) | 0.06% |
| Hardware, e-waste & supply chainE-waste for health: recycling smartphones for health monitoring | 24 | 0.01% | 7 (29.2%) | 0.01% |
| Concentration of compute powerDemonopolizing Medical Knowledge | 16 | 0.01% | 7 (43.8%) | 0.01% |
| Labour & data workNew Work—New Interventions: Digital Occupational Health Interventions and the Co-Creation of a Human-Centered Future of | 11 | 0.01% | 6 (54.5%) | 0.01% |
| Energy & datacenter footprintSUSTAINABLE GREEN COMPUTING FOR MEDICAL APPLICATIONS: ADVANCING RESPONSIBLE HEALTHCARE IT | 10 | 0.01% | 4 (40.0%) | 0.01% |
| Carbon & emissions of computeSustainable AI-Enabled UAV Healthcare Logistics: Environmental, Social, and Governance Implications from a PRISMA-ScR Re | 3 | 0.0% | 1 (33.3%) | 0.0% |
| Water use | 0 | 0.0% | 0 (%) | 0.0% |
Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.
Published patent filings in the recorded source window.
Company counts, hiring and disclosed funding across the recorded hubs.
57.9% across the displayed hubs
13 companies hiring · $607.0M disclosed funding
Explore companies in Copenhagen ↗
13.7% across the displayed hubs
1 companies hiring · $83.2M disclosed funding
Explore companies in Aarhus ↗
7.4% across the displayed hubs
2 companies hiring · $139.8M disclosed funding
Explore companies in Odense ↗
4.8% across the displayed hubs
0 companies hiring · $29.3M disclosed funding
Explore companies in Horsholm ↗
4.8% across the displayed hubs
0 companies hiring · $8.9M disclosed funding
Explore companies in Aalborg ↗
4.4% across the displayed hubs
1 companies hiring · $45.7M disclosed funding
Explore companies in Ballerup ↗
3.7% across the displayed hubs
3 companies hiring · $121.4K disclosed funding
Explore companies in Vejle ↗
3.3% across the displayed hubs
0 companies hiring · $7.8M disclosed funding
Explore companies in Frederiksberg ↗Clear definitions for making better comparisons.
It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.
No. A company can belong to several segments, so segment counts and funding can overlap.
A dash or unavailable panel means the current reviewed source snapshot does not support that figure.
Company ecosystem snapshot: 2 September 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.
Canonical landscape ↗